ADYNOVATE

ADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congential factor VIII deficiency) for:

  • On-demand treatment and control of bleeding episodes
  • Routine prophylaxis to reduce the frequency of bleeding episodes

ADYNOVATE is not indicated for the treatment of von Willebrand disesase.

For indications, dosing and other information, please refer to the prescribing information.

 

ADYNOVATE ‐ Baxalta

Size:
250 unit, 5 mL
NDC #:
00944-4252-02
Download:
PI
Size:
500 unit, 5 mL
NDC #:
00944-4254-02
Download:
PI
Size:
1000 unit, 5 mL
NDC #:
00944-4256-02
Download:
PI
Size:
2000 unit, 5 mL
NDC #:
00944-4258-02
Download:
PI